Michael Patrick Murphy, MD
Otolaryngology · San Ramon
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
Offices
1 location · University Healthcare Alliance · 334 clinicians in this group
Looking this up.
Hospitals listed: John Muir Medical Center - Concord Campus · John Muir Medical Center - Walnut Creek Campus · Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Murphy’s office at (925) 242-0647 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A79494 · Current
Licensed to practise in California · since 2002 · expires 2028-04-30 · Saint Louis University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- John Muir Medical Center - Concord CampusConcord, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of John Muir Health, which runs 3 hospitalsPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.235, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.675, Oct 2024 – Sep 2025
- John Muir Medical Center - Walnut Creek CampusWalnut Creek, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of John Muir Health, which runs 3 hospitalsPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Abdominopelvic accidental puncture or laceration rate: 2.01 (1.17 to 2.85) · 2,206 cases, Jul 2022 – Jun 2024Worse than the national rate — Death rate among surgical inpatients with serious treatable complications: 222.42 (177.82 to 267.02) · 120 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.4 (0.91 to 1.9) · 9,764 cases, Jul 2022 – Jun 2024Worse than the national rate — SSI - Colon Surgery: 2.734, Oct 2024 – Sep 2025Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.536, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.341, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.455, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.245, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for John Muir Medical Center - Concord Campus
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.235 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.675 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.11 (0.21 to 2) · 1,612 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.77 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 184.13 (136.65 to 231.6) · 86 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.2 · 175 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.6 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.4 · 172 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8 · 537 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.5 · 434 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13 · 215 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 3,208 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.32 (0.13 to 0.51) · 7,626 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,660 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.1 (1.29 to 4.91) · 2,723 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.21 (0 to 2.51) · 1,208 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3 (1.7 to 4.3) · 2,355 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.77 (3.24 to 12.3) · 1,216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.43 (0.43 to 6.43) · 1,253 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.93 (0.47 to 3.4) · 388 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.14 (0.58 to 1.69) · 6,288 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 263 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.636 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.254 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.904 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.5 · 312 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.1 · 768 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -6.8 · 295 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.1 · 648 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 31.1 · 433 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 504 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.7 (5.1 to 8.8) · 476 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.9 (10.5 to 15.7) · 476 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 8.8 · 154 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.7 · 186 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (9.9 to 17.9) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.2) · 546 cases | No different | Jan 2024 – Dec 2024 |
What patients said (521 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
See every measure and the patient survey for John Muir Medical Center - Walnut Creek Campus
Behind the star rating — Deaths: 3 better, 2 the same, 2 worse of 7 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 3 better, 5 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 2.01 (1.17 to 2.85) · 2,206 cases | Worse | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 222.42 (177.82 to 267.02) · 120 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.4 (0.91 to 1.9) · 9,764 cases | Worse | Jul 2022 – Jun 2024 |
| SSI - Colon SurgeryInfections | 2.734 | Worse | Oct 2024 – Sep 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.536 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.341 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.455 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.245 | Better | Oct 2024 – Sep 2025 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.14 (0.87 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 131 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 148 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 695 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.5 · 827 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.1 · 509 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 4,483 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.35 (0.18 to 0.53) · 11,630 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.05 to 0.39) · 11,793 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.69 to 4.96) · 3,268 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.37 (0 to 2.94) · 1,631 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.76 (1.43 to 4.09) · 3,066 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.12 (0.22 to 12.02) · 1,580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.43 (1.21 to 7.64) · 1,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 685 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 615 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 1.88 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 93 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 729 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.1 · 91 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13 · 736 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 34.8 · 842 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 818 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.3 to 8.4) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.2 to 15.5) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 584 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 139 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.9) · 222 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 321 cases | No different | Jan 2024 – Dec 2024 |
What patients said (758 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$180,939
Medicare paid this office $180,939 for 940 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 400 | $41,561 | $81 |
| Return visit (30+ min) | 286 | $40,592 | $116 |
| New patient visit (30+ min) | 217 | $20,400 | $94 |
| New patient visit (45+ min) | 141 | $19,643 | $139 |
| Diagnostic exam of voice box using a flexible endoscope | 96 | $12,566 | $127 |
See all 15 services
| Short return visit (20+ min) | 400 | $41,561 | $81 |
| Return visit (30+ min) | 286 | $40,592 | $116 |
| New patient visit (30+ min) | 217 | $20,400 | $94 |
| New patient visit (45+ min) | 141 | $19,643 | $139 |
| Diagnostic exam of voice box using a flexible endoscope | 96 | $12,566 | $127 |
| Short return visit | 162 | $9,234 | $49 |
| Removal of impacted ear wax | 143 | $7,190 | $42 |
| Exam to assess movement of vocal cord flaps using an endoscope | 31 | $6,021 | $194 |
| Diagnostic exam of nasal passages using an endoscope | 24 | $5,241 | $194 |
| New patient visit (15+ min) | 79 | $4,172 | $53 |
| Simple control of nose bleed | 19 | $2,923 | $139 |
| Sleep study including heart rate, breathing, and sleep time | 16 | $2,280 | $142 |
| Therapy procedure using a positive pressure ventilator | 15 | $938 | $59 |
| Evaluation, recording, and interpretation of swallowing using an endoscope | 21 | $719 | $33 |
| Repositioning exercises of head for treatment of dizziness, each day | 17 | $714 | $40 |
Who their Medicare patients are
940 Original Medicare patients in 2024. Average age 77 · Under 65 3% · 85 and older 18% · Women 60% · Also on Medicaid 7% · Health risk score 1.19. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 68% · Coronary heart disease 24% · Chronic kidney disease 22% · Cancer 21% · Atrial fibrillation 20% · Diabetes 19% · Depression 18% · Heart failure 14% · COPD 12% · Stroke 7% · Dementia 4%.
The office billed $812,515, Medicare allowed $245,451 and paid $180,939; for 2,134 services of 36 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 940 | 2,134 | 77 | 1.19 | $812,515 | $180,939 |
| 2023 | 966 | 2,023 | 76 | 1.11 | $772,686 | $175,974 |
| 2022 | 938 | 1,975 | 77 | 1.15 | $756,885 | $174,283 |
| 2021 | 908 | 1,921 | 76 | 1.07 | $746,096 | $178,970 |
| 2020 | 735 | 1,629 | 77 | 1.12 | $627,271 | $128,029 |
| 2019 | 900 | 2,102 | 76 | 1.07 | $856,519 | $181,512 |
| 2018 | 778 | 1,839 | 76 | 1.11 | $726,857 | $170,076 |
| 2017 | 730 | 1,793 | 76 | 1.14 | $632,611 | $156,020 |
| 2016 | 749 | 1,725 | 76 | 1.08 | $562,952 | $154,386 |
| 2015 | 561 | 1,268 | 76 | 1.08 | $223,278 | $123,206 |
| 2014 | 504 | 1,200 | 76 | 1.10 | $204,750 | $114,085 |
| 2013 | 464 | 1,103 | 75 | 1.00 | $197,908 | $110,794 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Short return visit (20+ min) | 401 | $41,173 | $79 |
| Return visit (30+ min) | 270 | $35,677 | $114 |
| New patient visit (45+ min) | 200 | $27,726 | $139 |
| New patient visit (30+ min) | 214 | $19,605 | $92 |
| Diagnostic exam of voice box using a flexible endoscope | 88 | $11,021 | $125 |
| Short return visit | 167 | $9,562 | $49 |
| Removal of impacted ear wax | 164 | $7,663 | $41 |
| New patient visit (15+ min) | 92 | $5,250 | $57 |
| Exam to assess movement of vocal cord flaps using an endoscope | 23 | $4,753 | $190 |
| Simple control of nose bleed | 19 | $3,500 | $159 |
| Diagnostic exam of nasal passages using an endoscope | 14 | $2,692 | $192 |
| Evaluation, recording, and interpretation of swallowing using an endoscope | 27 | $833 | $31 |
| Repositioning exercises of head for treatment of dizziness, each day | 16 | $645 | $34 |
2022: 15 services
| Short return visit (20+ min) | 356 | $36,857 | $78 |
| Return visit (30+ min) | 222 | $29,555 | $112 |
| New patient visit (45+ min) | 204 | $29,236 | $143 |
| New patient visit (30+ min) | 243 | $21,718 | $89 |
| Diagnostic exam of voice box using a flexible endoscope | 126 | $15,880 | $123 |
| Short return visit | 151 | $8,346 | $47 |
| Removal of impacted ear wax | 173 | $7,803 | $39 |
| New patient visit (15+ min) | 77 | $4,592 | $60 |
| Exam to assess movement of vocal cord flaps using an endoscope | 19 | $3,509 | $185 |
| Diagnostic exam of nasal passages using an endoscope | 16 | $2,835 | $177 |
| Simple control of nose bleed | 17 | $2,740 | $152 |
| Long return visit (40+ min) | 12 | $2,055 | $171 |
| Repositioning exercises of head for treatment of dizziness, each day | 22 | $928 | $37 |
| Evaluation, recording, and interpretation of swallowing using an endoscope | 25 | $758 | $30 |
| Sleep study including heart rate, breathing, and sleep time | 16 | $522 | $33 |
2021: 13 services
| Short return visit (20+ min) | 356 | $38,495 | $83 |
| Return visit (30+ min) | 232 | $30,536 | $117 |
| New patient visit (45+ min) | 204 | $30,166 | $148 |
| New patient visit (30+ min) | 217 | $21,585 | $99 |
| Diagnostic exam of voice box using a flexible endoscope | 92 | $10,370 | $113 |
| Removal of impacted ear wax | 227 | $9,706 | $38 |
| Short return visit | 131 | $7,840 | $51 |
| Exam to assess movement of vocal cord flaps using an endoscope | 40 | $7,227 | $181 |
| New patient visit (15+ min) | 77 | $4,950 | $64 |
| Diagnostic exam of nasal passages using an endoscope | 19 | $3,888 | $194 |
| Simple control of nose bleed | 17 | $2,865 | $159 |
| Evaluation, recording, and interpretation of swallowing using an endoscope | 18 | $548 | $30 |
| Repositioning exercises of head for treatment of dizziness, each day | 13 | $437 | $34 |
2020: 11 services
| New patient visit (45+ min) | 160 | $24,021 | $150 |
| Return visit (30+ min) | 199 | $22,743 | $98 |
| Short return visit (20+ min) | 221 | $18,314 | $66 |
| New patient visit (30+ min) | 153 | $13,508 | $88 |
| Diagnostic exam of voice box using a flexible endoscope | 93 | $9,579 | $103 |
| Short return visit | 187 | $8,871 | $38 |
| Removal of impacted ear wax | 153 | $6,370 | $37 |
| Diagnostic exam of nasal passages using an endoscope | 27 | $4,806 | $178 |
| Simple control of nose bleed | 25 | $3,505 | $125 |
| New patient visit (15+ min) | 44 | $2,708 | $62 |
| Repositioning exercises of head for treatment of dizziness, each day | 16 | $809 | $43 |
2019: 11 services
| New patient visit (45+ min) | 295 | $42,204 | $143 |
| Return visit (30+ min) | 291 | $34,673 | $94 |
| Short return visit (20+ min) | 320 | $28,372 | $66 |
| Diagnostic exam of voice box using a flexible endoscope | 172 | $19,598 | $105 |
| New patient visit (30+ min) | 150 | $13,542 | $90 |
| Diagnostic exam of nasal passages using an endoscope | 55 | $11,379 | $190 |
| Short return visit | 157 | $8,566 | $43 |
| Removal of impacted ear wax | 157 | $6,906 | $36 |
| Simple control of nose bleed | 27 | $4,188 | $131 |
| Repositioning exercises of head for treatment of dizziness, each day | 23 | $1,031 | $36 |
| New patient visit (15+ min) | 16 | $958 | $60 |
2018: 10 services
| Return visit (30+ min) | 276 | $38,166 | $94 |
| New patient visit (45+ min) | 259 | $37,506 | $145 |
| Short return visit (20+ min) | 261 | $21,640 | $63 |
| Diagnostic exam of voice box using a flexible endoscope | 152 | $17,049 | $103 |
| New patient visit (30+ min) | 171 | $15,788 | $92 |
| Diagnostic exam of nasal passages using an endoscope | 68 | $14,545 | $202 |
| Removal of impacted ear wax | 138 | $6,817 | $39 |
| Short return visit | 81 | $3,651 | $39 |
| Simple control of nose bleed | 13 | $1,806 | $120 |
| Repositioning exercises of head for treatment of dizziness, each day | 18 | $891 | $36 |
2017: 12 services
| Return visit (30+ min) | 281 | $34,359 | $89 |
| New patient visit (45+ min) | 225 | $31,035 | $138 |
| Short return visit (20+ min) | 262 | $24,526 | $65 |
| New patient visit (30+ min) | 164 | $15,495 | $94 |
| Diagnostic exam of voice box using a flexible endoscope | 132 | $14,003 | $95 |
| Diagnostic exam of nasal passages using an endoscope | 52 | $10,887 | $191 |
| Removal of impacted ear wax | 161 | $7,222 | $38 |
| Complex control of nose bleed | 13 | $3,622 | $213 |
| Short return visit | 63 | $2,853 | $38 |
| Simple control of nose bleed | 12 | $1,093 | $84 |
| Repositioning exercises of head for treatment of dizziness, each day | 15 | $735 | $35 |
| New patient visit (15+ min) | 11 | $693 | $63 |
2016: 10 services
| Return visit (30+ min) | 381 | $47,812 | $86 |
| New patient visit (45+ min) | 302 | $40,480 | $134 |
| Diagnostic exam of voice box using a flexible endoscope | 128 | $14,276 | $103 |
| Diagnostic exam of nasal passages using an endoscope | 50 | $12,113 | $199 |
| New patient visit (30+ min) | 114 | $9,870 | $87 |
| Removal of impacted ear wax | 173 | $8,458 | $41 |
| Short return visit (20+ min) | 102 | $7,551 | $62 |
| Complex control of nose bleed | 20 | $4,309 | $205 |
| Repositioning exercises of head for treatment of dizziness, each day | 16 | $724 | $34 |
| Short return visit | 16 | $673 | $40 |
2015: 9 services
| Return visit (30+ min) | 285 | $39,438 | $88 |
| New patient visit (45+ min) | 271 | $35,690 | $132 |
| Diagnostic exam of voice box using a flexible endoscope | 100 | $11,201 | $103 |
| Exam to assess movement of vocal cord flaps using an endoscope | 36 | $6,658 | $185 |
| Short return visit (20+ min) | 72 | $4,959 | $56 |
| Diagnostic exam of nasal passages using an endoscope | 21 | $4,459 | $194 |
| New patient visit (30+ min) | 54 | $4,397 | $81 |
| Removal of impacted ear wax | 56 | $2,470 | $40 |
| Repositioning exercises of head for treatment of dizziness, each day | 12 | $461 | $35 |
2014: 9 services
| Return visit (30+ min) | 203 | $28,256 | $91 |
| New patient visit (45+ min) | 152 | $20,412 | $134 |
| Diagnostic exam of voice box using a flexible endoscope | 95 | $11,953 | $104 |
| Short return visit (20+ min) | 133 | $11,725 | $60 |
| New patient visit (30+ min) | 114 | $9,945 | $87 |
| Exam to assess movement of vocal cord flaps using an endoscope | 43 | $8,148 | $189 |
| Diagnostic exam of nasal passages using an endoscope | 21 | $4,612 | $192 |
| Short return visit | 41 | $1,723 | $34 |
| Diagnostic exam of voice box using a flexible endoscope | 11 | $1,370 | $49 |
2013: 10 services
| Return visit (30+ min) | 158 | $18,747 | $85 |
| New patient visit (45+ min) | 119 | $15,992 | $134 |
| Diagnostic exam of voice box using a flexible endoscope | 103 | $11,622 | $106 |
| Exam to assess movement of vocal cord flaps using an endoscope | 53 | $10,957 | $192 |
| Short return visit (20+ min) | 125 | $9,318 | $60 |
| Diagnostic exam of nasal passages using an endoscope | 28 | $8,247 | $206 |
| New patient visit (30+ min) | 99 | $8,184 | $83 |
| Complex control of nose bleed | 20 | $4,294 | $195 |
| Short return visit | 60 | $4,244 | $37 |
| New patient visit (15+ min) | 37 | $2,261 | $61 |
Drugs they prescribed that Part D paid
$20,616
Pharmacies billed $20,616 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
720 generic and fewer than 11 brand-name prescriptions · $20,616 in drug cost · 113 antibiotic prescriptions to 84 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ipratropium | 400 | $16,070 | $40 |
| Ofloxacin | 33 | $1,066 | $32 |
| Azelastine | 27 | $483 | $18 |
| Cefuroxime | 40 | $467 | $12 |
| Mupirocin | 53 | $375 | $7 |
See all 10 drugs
| Ipratropium | 400 | $16,070 | $40 |
| Ofloxacin | 33 | $1,066 | $32 |
| Azelastine | 27 | $483 | $18 |
| Cefuroxime | 40 | $467 | $12 |
| Mupirocin | 53 | $375 | $7 |
| Clarithromycin | 16 | $196 | $12 |
| Amitriptyline | 13 | $146 | $11 |
| Doxycycline Hyclate | 22 | $137 | $6 |
| Clindamycin | 21 | $107 | $5 |
| Prednisone | 29 | $98 | $3 |
Year by year
| 2024 | 723 | 353 | None | None | $20,616 |
| 2023 | 672 | 358 | None | None | $24,715 |
| 2022 | 675 | 359 | None | None | $26,405 |
| 2021 | 609 | 318 | None | None | $22,668 |
| 2020 | 542 | 259 | None | 2% | $18,714 |
| 2019 | 637 | 297 | None | 3% | $19,452 |
| 2018 | 491 | 247 | None | 3% | $16,122 |
| 2017 | 486 | 216 | None | 4% | $19,096 |
| 2016 | 478 | 220 | None | 9% | $22,362 |
| 2015 | 401 | 194 | None | 12% | $17,050 |
| 2014 | 380 | 175 | None | 18% | $18,975 |
| 2013 | 289 | 145 | 4% (11) | 25% | $16,189 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Ipratropium | 354 | $17,526 | $50 |
| Ofloxacin | 35 | $2,830 | $81 |
| Azelastine | 15 | $435 | $29 |
| Mupirocin | 48 | $380 | $8 |
| Doxycycline Hyclate | 35 | $356 | $10 |
| Cefuroxime | 24 | $343 | $14 |
| Clarithromycin | 12 | $261 | $22 |
| Clindamycin | 29 | $235 | $8 |
| Amitriptyline | 14 | $144 | $10 |
| Prednisone | 31 | $77 | $2 |
2022: 11 drugs
| Ipratropium | 372 | $18,790 | $51 |
| Ofloxacin | 24 | $2,923 | $122 |
| Cefuroxime | 40 | $774 | $19 |
| Azelastine | 18 | $702 | $39 |
| Mupirocin | 62 | $576 | $9 |
| Clarithromycin | 14 | $224 | $16 |
| Doxycycline Hyclate | 18 | $134 | $7 |
| Clindamycin | 18 | $92 | $5 |
| Prednisone | 12 | $43 | $4 |
| Triamterene-Hydrochlorothiazid | 13 | $43 | $3 |
| Triamcinolone Acetonide | 15 | $38 | $3 |
2021: 10 drugs
| Ipratropium | 341 | $17,082 | $50 |
| Ofloxacin | 21 | $1,174 | $56 |
| Azelastine | 16 | $658 | $41 |
| Cefuroxime | 31 | $579 | $19 |
| Mupirocin | 39 | $299 | $8 |
| Clindamycin | 16 | $98 | $6 |
| Ciprofloxacin | 19 | $61 | $3 |
| Triamcinolone Acetonide | 13 | $59 | $5 |
| Triamterene-Hydrochlorothiazid | 12 | $53 | $4 |
| Prednisone | 11 | $34 | $3 |
2020: 6 drugs
| Ipratropium | 275 | $11,220 | $41 |
| Azelastine | 37 | $1,579 | $43 |
| Cefuroxime | 32 | $828 | $26 |
| Mupirocin | 57 | $466 | $8 |
| Clindamycin | 21 | $130 | $6 |
| Triamcinolone Acetonide | 11 | $26 | $2 |
2019: 9 drugs
| Ipratropium | 311 | $10,261 | $33 |
| Ciprodex | 15 | $3,595 | $240 |
| Azelastine | 45 | $1,982 | $44 |
| Cefuroxime | 54 | $1,246 | $23 |
| Clarithromycin | 18 | $426 | $24 |
| Mupirocin | 47 | $407 | $9 |
| Clindamycin | 20 | $125 | $6 |
| Prednisone | 29 | $111 | $4 |
| Triamcinolone Acetonide | 26 | $62 | $2 |
2018: 8 drugs
| Azelastine | 91 | $4,338 | $48 |
| Ipratropium | 112 | $4,242 | $38 |
| Ciprodex | 17 | $3,807 | $224 |
| Cefuroxime | 70 | $1,559 | $22 |
| Clarithromycin | 17 | $446 | $26 |
| Mupirocin | 43 | $345 | $8 |
| Clindamycin | 34 | $256 | $8 |
| Prednisone | 29 | $119 | $4 |
2017: 10 drugs
| Azelastine | 75 | $4,398 | $59 |
| Ciprodex | 19 | $3,832 | $202 |
| Ipratropium | 97 | $2,993 | $31 |
| Mupirocin | 23 | $2,783 | $121 |
| Cefuroxime | 57 | $1,587 | $28 |
| Clarithromycin | 32 | $977 | $31 |
| Fluticasone Propionate | 35 | $541 | $15 |
| Mupirocin | 23 | $189 | $8 |
| Clindamycin | 26 | $147 | $6 |
| Prednisone | 17 | $72 | $4 |
2016: 9 drugs
| Azelastine | 108 | $10,284 | $95 |
| Ciprodex | 25 | $4,712 | $188 |
| Cefuroxime | 51 | $2,186 | $43 |
| Ipratropium | 67 | $1,564 | $23 |
| Fluticasone Propionate | 90 | $973 | $11 |
| Clindamycin | 20 | $173 | $9 |
| Mupirocin | 16 | $170 | $11 |
| Prednisone | 16 | $90 | $6 |
| Sulfamethoxazole-Trimethoprim | 11 | $55 | $5 |
2015: 9 drugs
| Azelastine | 94 | $7,212 | $77 |
| Ciprodex | 19 | $3,333 | $175 |
| Cefuroxime | 28 | $1,210 | $43 |
| Ipratropium | 40 | $869 | $22 |
| Fluticasone Propionate | 83 | $777 | $9 |
| Clarithromycin | 16 | $601 | $38 |
| Mupirocin | 25 | $242 | $10 |
| Clindamycin | 13 | $101 | $8 |
| Prednisone | 12 | $58 | $5 |
2014: 10 drugs
| Ciprodex | 22 | $3,452 | $157 |
| Azelastine | 43 | $3,136 | $73 |
| Astepro | 13 | $1,468 | $113 |
| Cefuroxime | 24 | $1,190 | $50 |
| Fluticasone Propionate | 82 | $1,146 | $14 |
| Ipratropium | 28 | $642 | $23 |
| Clarithromycin | 11 | $587 | $53 |
| Cefdinir | 11 | $454 | $41 |
| Amox Tr-Potassium Clavulanate | 17 | $288 | $17 |
| Mupirocin | 23 | $247 | $11 |
2013: 7 drugs
| Astepro | 22 | $2,688 | $122 |
| Fluticasone Propionate | 62 | $1,612 | $26 |
| Bactroban Nasal | 14 | $1,574 | $112 |
| Azelastine | 11 | $747 | $68 |
| Cefuroxime | 28 | $530 | $19 |
| Mupirocin | 20 | $276 | $14 |
| Amox Tr-Potassium Clavulanate | 11 | $241 | $22 |
Money from drug and device companies
$308 in 2025
| 2025 | 3 | 8 | None | $308 |
| 2024 | 1 | 8 | None | $586 |
| 2023 | 3 | 3 | None | $185 |
| 2022 | 1 | 1 | None | $17 |
| 2021 | 5 | 8 | $37 | $144 |
| 2020 | 1 | 1 | None | $947 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Integra LifeSciences | Acclarent Aera | $168 | 2 payments
|
| Smith+Nephew | Halo | $118 | 5 payments
|
| GlaxoSmithKline | Nucala | $22 | 1 payment
|
See all 8 published payments
| Smith+Nephew | Meals · 2025-12-16 | Halo | $18 |
| Smith+Nephew | Meals · 2025-11-20 | Halo | $16 |
| Integra LifeSciences | Meals · 2025-06-11 | Acclarent Aera | $26 |
| Integra LifeSciences | Meals · 2025-06-11 | Acclarent Aera | $143 |
| Smith+Nephew | Meals · 2025-05-28 | Halo | $23 |
| Smith+Nephew | Meals · 2025-05-28 | Halo | $38 |
| Smith+Nephew | Meals · 2025-04-03 | Halo | $23 |
| GlaxoSmithKline | Meals · 2025-03-19 | Nucala | $22 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $586
| Medtronic | Ellipsys Vascular Access System | $586 | 8 payments
|
2023: $185
| Medtronic | Sinuva | $151 | 1 payment
|
| ALK-Abello | Odactra | $18 | 1 payment
|
| Philips Electronics North America | (6582) Visions 035 | $16 | 1 payment
|
2022: $17
| Medtronic | Ellipsys Vascular Access System | $17 | 1 payment
|
2021: $144
| ALK-Abello | Otiprio | $40 | 3 payments
|
| Itamar Medical | Watchpat | $37 | 1 payment
|
| Medtronic | Ellipsys | $27 | 1 payment
|
| Intersect ENT | Vensure | $25 | 1 payment
|
| OptiNose US | Xhance | $16 | 1 payment
|
2020: $947
| Inspire Medical Systems | Inspire Upper Airway Stimulation System | $947 | 1 payment
|
Professional record
- NPI
- 1013964410
- Licence
- CA A79494California A79494: Current · expires 2028-04-30
- Trained
- Saint Louis University School of Medicine, 1994
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Otolaryngology (207Y00000X); Federal specialty code 207RS0012X (207RS0012X)
- Mailing address
- 2623 Shadelands Dr Ste 1, Walnut Creek, CA, 94598
- NPI first listed
- 2006-05-30
- NPI last updated
- 2024-04-29
- NPI record certified
- 2024-04-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 725 Welch Rd, Palo Alto, CA, 94304 · 300 Pasteur Dr, Stanford, CA, 94305